JANX Janux Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$16,93
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$12,4252 haftanın en düşüğü
$35,3452 haftanın en yükseği
Piyasa Değeri (MRQ)
$1.03B
P/E (TTM)
-10.3
Hisse Başına Kâr (TTM)
$-1.64
Gelir (TTM)
$24M
rozetleriniz
52 Haftlık Aralık
$12–$35
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$36
P/E
-10.3
ROE
-10.7%
Net Kâr Marjı
-427.5%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
JANX Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$16.93
Piyasa Değeri (MRQ)
$1.03B
P/E (TTM)
-10.3
Hisse Başına Kâr (TTM)
$-1.64
Gelir (TTM)
$24M
ROE (TTM)
-10.7%
52 Haftlık Aralık
$12–$35
JANX Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$10M2020-12-31 → 2025-12-31
Hisse Başına Kâr$-1.832021-12-31 → 2025-12-31
Serbest Nakit Akışı$-83M2021-12-31 → 2025-12-31
Net kar marjı-427.5%2021-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | JANX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -10.35Y ort. ≈-16.1 | ≈-16.1 | · | · | |
| F/S (TTM) | 43.15Y ort. ≈146.2 | ≈146.2 | 12.6 | Aşırı değerli | |
| F/D (MRQ) | 1.15Y ort. ≈1.9 | ≈1.9 | 4.2 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -24.75Y ort. ≈-29.2 | ≈-29.2 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -25.15Y ort. ≈-30.6 | ≈-30.6 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.15Y ort. ≈1.9 | ≈1.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | JANX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -598.1%5Y ort. ≈-1019.5% | ≈-1019.5% | -329.2% | Aynı seviyede | |
| EBITDA Margin (FAVÖK Marjı) | -1576.7%5Y ort. ≈-1019.5% | ≈-1019.5% | -329.2% | Aynı seviyede | |
| Net Kâr Marjı (TTM) | -427.5%5Y ort. ≈-827.9% | ≈-827.9% | -270.7% | En üst düzey | |
| ROA (TTM) | -10.1%5Y ort. ≈-13.9% | ≈-13.9% | -29.5% | En üst düzey | |
| ROE (TTM) | -10.7%5Y ort. ≈-13.0% | ≈-13.0% | -18.5% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | JANX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 16.35Y ort. ≈34.9 | ≈34.9 | 10.4 | Güçlü likidite | |
| Cari Oran (MRQ) | 16.15Y ort. ≈34.6 | ≈34.6 | 2.5 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | JANX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -5.5%5Y ort. ≈39.0% | ≈39.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 5.1% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | JANX | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.0 | ≈0.0 | 0.3 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$88.5K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
14.8%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 11, 2026 | $-0.35 | $-0.39 | 10.7% |
| 31 Mart 2026 | May 12, 2026 | $-0.39 | $-0.54 | 27.4% |
| 31 Aralık 2025 | $-0.51 | $-0.66 | 22.4% | |
| 30 Eylül 2025 | $-0.39 | $-0.63 | 38.1% | |
| 30 Haziran 2025 | $-0.55 | $-0.48 | -15.5% | |
| 31 Mart 2025 | $-0.38 | $-0.40 | 5.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $10M | $11M | $8M | $9M | $4M | $0 | |
| R&D Expense | $126M | $68M | $55M | $53M | $26M | $3M | |
| SG&A Expense | $42M | $41M | $26M | $22M | $10M | $2M | |
| Operating Income | $-158M | $-99M | $-73M | $-67M | $-33M | $-5M | |
| Other Non-op | $44M | $30M | $15M | $4M | $257.0K | $-2M | |
| Income Tax | $0 | $0 | $0 | · | · | · | |
| Net Income | $-114M | $-69M | $-58M | $-63M | $-33M | $-7M | |
| EPS (Basic) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · | |
| EPS (Diluted) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · | |
| Shares (Basic) | 61,966,999 | 53,751,480 | 44,016,283 | 41,469,631 | 23,530,252 | 233,726 | |
| Shares (Diluted) | 61,966,999 | 53,751,480 | 44,016,283 | 41,469,631 | 23,530,252 | · | |
| EBITDA | $-158M | $-99M | $-73M | $-67M | $-33M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $431M | $19M | $51M | $36M | $8M | |
| Short-term Investments | $914M | $595M | $325M | $276M | $339M | $0 | |
| Receivables | $0 | · | $0 | $0 | $0 | $8M | |
| Prepaid Expense | $9M | $8M | $5M | $5M | $2M | $249.0K | |
| Current Assets | $976M | $1.03B | $349M | $332M | $377M | $16M | |
| PP&E (Net) | $4M | $5M | $7M | $7M | $1M | $155.0K | |
| PP&E (Gross) | $11M | $10M | $10M | $8M | $2M | $176.0K | |
| Accum. Depreciation | $7M | $5M | $3M | $972.0K | $131.0K | $21.0K | |
| Other Non-current Assets | $3M | $3M | $3M | $1M | $392.0K | $0 | |
| Total Assets | $1.00B | $1.06B | $380M | $364M | $380M | $16M | |
| Accounts Payable | $5M | $4M | $2M | $2M | $2M | $428.0K | |
| Accrued Liabilities | $18M | $12M | $7M | $8M | $4M | $751.0K | |
| Current Liabilities | $25M | $17M | $13M | $17M | $13M | $3M | |
| Capital Leases | $20M | $21M | $23M | $25M | $0 | $0 | |
| Total Liabilities | $45M | $39M | $36M | $43M | $13M | $9M | |
| Common Stock | $60.0K | $59.0K | $46.0K | $42.0K | $41.0K | $1.0K | |
| Retained Earnings | $-351M | $-238M | $-169M | $-110M | $-47M | $-15M | |
| AOCI | $4M | $2M | $665.0K | $-2M | $-270.0K | $0 | |
| Stockholders' Equity | $957M | $1.02B | $344M | $321M | $366M | $-15M | |
| Liabilities + Equity | $1.00B | $1.06B | $380M | $364M | $380M | $16M | |
| Shares Outstanding | 60,384,283 | 59,064,606 | 46,252,440 | 41,616,260 | 41,243,137 | 1,046,599 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $33M | $20M | $17M | $7M | $72.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-82M | $-44M | $-51M | $-43M | $-17M | $-4M | |
| CapEx | $1M | $359.0K | $2M | $6M | $1M | $0 | |
| Investing Cash Flow | $-301M | $-258M | $-41M | $58M | $-341M | $0 | |
| Financing Cash Flow | $5M | $713M | $60M | $500.0K | $387M | $12M | |
| Free Cash Flow | $-83M | $-44M | $-52M | $-49M | $-18M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | · | |
| Net Margin | -1136.2% | -651.6% | -721.2% | -732.2% | -898.3% | · | |
| EBITDA Margin | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% | · | |
| ROA | -11.0% | -9.6% | -15.7% | -17.0% | -16.5% | · | |
| ROE | -11.7% | -8.2% | -16.8% | -19.3% | -8.8% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 39.0 | 59.2 | 26.8 | 20.1 | 29.5 | · | |
| Quick Ratio | 38.7 | 58.7 | 26.4 | 19.8 | 29.3 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | · | · | 0.9 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.85 | $17.32 | $7.45 | $7.71 | $8.88 | · | |
| Revenue / Share | $0.16 | $0.20 | $0.18 | $0.21 | · | · | |
| Cash Flow / Share | $-1.33 | $-0.82 | $-1.15 | $-1.03 | · | · | |
| Cash / Share | $0.87 | $7.29 | $0.42 | $1.24 | $0.86 | · | |
| EPS (TTM) | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -5.5% | 31.0% | -6.1% | 136.8% | · | · | |
| Revenue CAGR 3Y | 5.1% | 42.8% | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $11M | $8M | $9M | $4M | · | |
| Net Income TTM | $-114M | $-69M | $-58M | $-63M | $-33M | · | |
| Market Cap | $833M | $3.16B | $496M | $548M | $814M | · | |
| P/E | -7.5 | -41.8 | -8.1 | -8.7 | -14.2 | · | |
| P/S | 83.3 | 298.7 | 61.4 | 63.6 | 223.7 | · | |
| P/B | 0.9 | 3.1 | 1.4 | 1.7 | 2.2 | · | |
| P / Tangible Book | 0.9 | 3.1 | 1.4 | 1.7 | 2.2 | · | |
| P / Cash Flow | -10.1 | -72.2 | -9.8 | -12.8 | -47.9 | · | |
| P / FCF | -10.0 | -71.6 | -9.5 | -11.1 | -44.1 | · | |
| Earnings Yield | -13.3% | -2.4% | -12.3% | -11.5% | -7.0% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10M | $4M | $0 | $10M | $0 | $0 | $0 | $439.0K | $9M | $1M | $3M | $1M | $2M | $2M | $2M | $2M | |
| R&D Expense | $31M | $27M | $32M | $35M | $35M | $25M | $21M | $19M | $15M | $14M | $12M | $15M | $16M | $14M | $14M | $10M | |
| SG&A Expense | $11M | $11M | $11M | $11M | $10M | $10M | $8M | $18M | $8M | $7M | $6M | $7M | $6M | $6M | $6M | $5M | |
| Operating Income | $-32M | $-34M | $-42M | $-35M | $-45M | $-35M | $-29M | $-36M | $-14M | $-20M | $-16M | $-21M | $-20M | $-18M | $-17M | $-14M | |
| Other Non-op | $10M | $10M | $10M | $11M | $11M | $11M | $9M | $8M | $8M | $5M | $4M | $3M | $3M | $1M | $373.0K | $132.0K | |
| Net Income | $-22M | $-24M | $-32M | $-24M | $-34M | $-24M | $-20M | $-28M | $-6M | $-15M | $-12M | $-18M | $-17M | $-17M | $-17M | $-13M | |
| EPS (Basic) | $-0.35 | $-0.39 | $-0.51 | $-0.39 | $-0.55 | $-0.38 | $-0.36 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | |
| EPS (Diluted) | $-0.35 | $-0.39 | $-0.51 | $-0.39 | $-0.55 | $-0.38 | $-0.36 | $-0.51 | $-0.11 | $-0.30 | $-0.25 | $-0.42 | $-0.42 | $-0.40 | $-0.41 | $-0.32 | |
| Shares (Basic) | 62,937,295 | 62,665,717 | · | 62,023,685 | 61,902,411 | 61,791,721 | · | 54,628,670 | 54,451,666 | 49,049,741 | 45,708,649 | 41,836,238 | 41,763,971 | 41,526,524 | 41,448,743 | 41,315,482 | |
| Shares (Diluted) | 62,937,295 | 62,665,717 | · | 62,023,685 | 61,902,411 | 61,791,721 | · | 54,628,670 | 54,451,666 | 49,049,741 | 45,708,649 | 41,836,238 | 41,763,971 | 41,526,524 | 41,448,743 | 41,315,482 | |
| EBITDA | $-32M | $-34M | · | $-35M | $-45M | $-35M | · | $-36M | $-14M | $-20M | $-16M | $-21M | $-20M | $-18M | $-17M | $-14M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $52M | $52M | $48M | $52M | $74M | $431M | $27M | $15M | $213M | $17M | $34M | $30M | $65M | $58M | $55M | |
| Short-term Investments | $943M | $905M | $914M | $941M | $944M | $940M | $595M | $631M | $632M | $439M | $333M | $270M | $287M | $274M | $296M | $306M | |
| Receivables | $149.0K | $35M | · | · | · | · | · | · | $8M | $519.0K | $0 | $0 | $750.0K | $500.0K | $0 | $0 | |
| Prepaid Expense | $12M | $11M | $9M | $9M | $10M | $9M | $8M | $8M | $8M | $6M | $5M | $6M | $4M | $5M | $4M | $3M | |
| Current Assets | $983M | $1.00B | $976M | $998M | $1.01B | $1.02B | $1.03B | $666M | $662M | $659M | $355M | $309M | $321M | $344M | $358M | $365M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | $7M | $7M | $7M | $7M | $7M | $4M | $3M | |
| PP&E (Gross) | $11M | $11M | $11M | $11M | $11M | $10M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $7M | $4M | $3M | |
| Accum. Depreciation | $8M | $7M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $1M | $567.0K | $320.0K | $212.0K | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $207.0K | $337.0K | |
| Total Assets | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M | $691M | $689M | $387M | $342M | $353M | $376M | $385M | $369M | |
| Accounts Payable | $3M | $3M | $5M | $3M | $3M | $2M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $2M | |
| Accrued Liabilities | $20M | $15M | $18M | $22M | $16M | $13M | $12M | $13M | $9M | $6M | $7M | $9M | $8M | $7M | $4M | $5M | |
| Current Liabilities | $60M | $59M | $25M | $28M | $21M | $18M | $17M | $17M | $12M | $11M | $14M | $18M | $16M | $16M | $13M | $13M | |
| Capital Leases | $18M | $19M | $20M | $20M | $20M | $21M | $21M | $22M | $22M | $23M | $23M | $24M | $24M | $24M | $23M | $0 | |
| Total Liabilities | $80M | $87M | $45M | $48M | $42M | $38M | $39M | $39M | $34M | $33M | $38M | $42M | $42M | $44M | $42M | $13M | |
| Common Stock | $61.0K | $60.0K | $60.0K | $60.0K | $59.0K | $59.0K | $59.0K | $52.0K | $52.0K | $51.0K | $46.0K | $42.0K | $42.0K | $42.0K | $42.0K | $41.0K | |
| Retained Earnings | $-398M | $-376M | $-351M | $-319M | $-295M | $-261M | $-238M | $-218M | $-189M | $-184M | $-157M | $-145M | $-128M | $-94M | $-78M | $-61M | |
| AOCI | $-2M | $576.0K | $4M | $5M | $4M | $4M | $2M | $8M | $-2M | $-524.0K | $-1M | $-1M | $-739.0K | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $928M | $942M | $957M | $977M | $991M | $1.01B | $1.02B | $656M | $658M | $656M | $349M | $299M | $311M | $332M | $344M | $356M | |
| Liabilities + Equity | $1.01B | $1.03B | $1.00B | $1.02B | $1.03B | $1.05B | $1.06B | $695M | $691M | $689M | $387M | $342M | $353M | $376M | $385M | $369M | |
| Shares Outstanding | 61,077,980 | 60,865,458 | 60,384,283 | 60,123,602 | 59,297,814 | 59,168,490 | 59,064,606 | 52,337,239 | 52,162,215 | 51,840,571 | 46,151,427 | 41,867,536 | 41,802,807 | 41,550,704 | 41,501,269 | 41,393,660 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $9M | $10M | $9M | $11M | $11M | $6M | $15M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | |
| Operating Cash Flow | $12M | $-12M | $-29M | $-13M | $-24M | $-17M | $-17M | $-2M | $-10M | $-15M | $-12M | $-15M | $-14M | $-13M | $-6M | $-12M | |
| CapEx | $202.0K | $273.0K | $106.0K | $93.0K | $473.0K | $371.0K | $42.0K | $25.0K | $95.0K | $197.0K | $470.0K | $580.0K | $285.0K | $3M | $898.0K | $971.0K | |
| Investing Cash Flow | $-39M | $8M | $30M | $8M | $2M | $-340M | $34M | $13M | $-191M | $-114M | $-61M | $18M | $-9M | $20M | $9M | $31M | |
| Financing Cash Flow | $2M | $4M | $3M | $493.0K | $954.0K | $554.0K | $387M | $2M | $3M | $322M | $57M | $528.0K | $2M | $0 | $308.0K | $1.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-17M | · | · | · | $-15M | · | · | $-14M | · | · | $-12M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -308.7% | -916.5% | · | -352.5% | · | · | · | -8164.5% | -155.4% | -1610.3% | -628.2% | -1962.9% | -990.3% | -994.0% | -729.9% | -852.2% | |
| Net Margin | -214.0% | -652.6% | · | -243.1% | · | · | · | -6391.6% | -67.0% | -1178.9% | -459.6% | -1656.4% | -852.5% | -920.9% | -714.1% | -843.9% | |
| EBITDA Margin | -308.7% | -916.5% | · | -352.5% | · | · | · | -8164.5% | -155.4% | -1610.3% | -628.2% | -1962.9% | -990.3% | -994.0% | -729.9% | -852.2% | |
| ROA | -2.1% | -2.3% | · | -2.8% | -3.9% | -2.7% | · | -5.2% | -1.1% | -2.8% | -3.0% | -4.8% | -4.8% | -4.3% | -4.3% | -7.3% | |
| ROE | -2.3% | -2.5% | · | -3.0% | -4.1% | -2.8% | · | -5.6% | -1.2% | -3.0% | -3.4% | -5.4% | -5.2% | -4.7% | -4.6% | -7.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.3 | 17.0 | · | 35.9 | 47.0 | 58.5 | · | 38.8 | 57.3 | 62.1 | 24.5 | 17.3 | 19.9 | 21.1 | 27.6 | 29.1 | |
| Quick Ratio | 16.1 | 16.8 | · | 35.5 | 46.6 | 57.9 | · | 38.3 | 56.6 | 61.5 | 24.2 | 16.9 | 19.7 | 20.8 | 27.3 | 28.9 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 2.7 | 0.2 | · | · | · | · | · | · | 2.4 | 2.0 | 10.1 | · | 5.5 | 7.3 | 12.6 | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.19 | $15.47 | · | $16.24 | $16.70 | $17.11 | · | $12.54 | $12.61 | $12.65 | $7.56 | $7.15 | $7.45 | $7.98 | $8.28 | $8.60 | |
| Revenue / Share | $0.16 | $0.06 | · | $0.16 | $0.00 | $0.00 | · | $0.01 | $0.16 | $0.03 | $0.06 | $0.03 | $0.05 | $0.04 | $0.06 | · | |
| Cash Flow / Share | · | $-0.20 | · | · | · | $-0.28 | · | · | · | $-0.30 | · | · | $-0.33 | · | · | · | |
| Cash / Share | $0.45 | $0.85 | · | $0.80 | $0.88 | $1.25 | · | $0.51 | $0.28 | $4.11 | $0.37 | $0.81 | $0.73 | $1.56 | $1.41 | $1.33 | |
| EPS (TTM) | $-1.64 | $-1.84 | · | $-1.68 | $-1.80 | $-1.36 | · | $-1.15 | $-0.89 | $-1.20 | $-1.48 | $-1.63 | $-1.62 | $-1.42 | $-1.28 | $-1.49 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $24M | $14M | · | $10M | $439.0K | $9M | · | $13M | $15M | $7M | $8M | $8M | $9M | $7M | $7M | $5M | |
| Net Income TTM | $-103M | $-114M | · | $-102M | $-106M | $-78M | · | $-61M | $-44M | $-56M | $-63M | $-68M | $-67M | $-60M | $-54M | $-44M | |
| Market Cap | $938M | $846M | · | $1.47B | $1.37B | $1.60B | · | $2.38B | $2.19B | $1.95B | $465M | $497M | $506M | $563M | $507M | $594M | |
| P/E | -9.4 | -7.6 | · | -14.5 | -12.8 | -19.9 | · | -39.5 | -47.1 | -31.4 | -6.8 | -7.3 | -7.5 | -9.5 | -9.5 | -9.6 | |
| P/S | 39.1 | 61.6 | · | 146.9 | 3120.2 | 171.1 | · | 182.2 | 144.4 | 267.8 | 54.9 | 64.0 | 55.8 | 76.2 | 75.3 | 122.5 | |
| P/B | 1.0 | 0.9 | · | 1.5 | 1.4 | 1.6 | · | 3.6 | 3.3 | 3.0 | 1.3 | 1.7 | 1.6 | 1.7 | 1.5 | 1.7 | |
| P / Tangible Book | 1.0 | 0.9 | · | 1.5 | 1.4 | 1.6 | · | 3.6 | 3.3 | 3.0 | 1.3 | 1.7 | 1.6 | 1.7 | 1.5 | 1.7 | |
| P / Cash Flow | · | -68.6 | · | · | · | -93.8 | · | · | · | -131.5 | · | · | -36.4 | · | · | -51.5 | |
| Earnings Yield | -10.7% | -13.2% | · | -6.9% | -7.8% | -5.0% | · | -2.5% | -2.1% | -3.2% | -14.7% | -13.7% | -13.4% | -10.5% | -10.5% | -10.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $10M | $11M | $8M | $9M | $4M |
| Faaliyet Kâr Marjı % | -1576.7% | -933.6% | -902.9% | -779.0% | -905.4% |
| Net Gelir | $-114M | $-69M | $-58M | $-63M | $-33M |
| Seyreltilmiş Hisse Başı Kâr | $-1.83 | $-1.28 | $-1.32 | $-1.52 | $-1.39 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 39.0 | 59.2 | 26.8 | 20.1 | 29.5 |
| Cari Oran | 38.7 | 58.7 | 26.4 | 19.8 | 29.3 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-83M | $-44M | $-52M | $-49M | $-18M |
Kurumsal Sahipler (13F) 217 dosya · $1.0B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
217
Tutulan Değer
$1.0B
Yeni pozisyonlar
40
Çıkan pozisyonlar
29
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 40 (-8 önceki Ç'ye göre) | 29 (+1 önceki Ç'ye göre) | 81 (+12 önceki Ç'ye göre) | 49 (-5 önceki Ç'ye göre) | +700K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $171.873.684 | 11.189.693 | 16,64% | Hisse senetleri |
| BlackRock, Inc. | $94.228.481 | 6.134.667 | 9,12% | Hisse senetleri |
| Prosight Management, LP | $58.436.828 | 3.804.481 | 5,66% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $58.279.971 | 4.196.409 | 5,64% | Hisse senetleri |
| STATE STREET CORP | $46.155.249 | 3.004.899 | 4,47% | Hisse senetleri |
| VANGUARD GROUP INC | $40.108.126 | 2.906.386 | 3,88% | Hisse senetleri |
| FMR LLC | $37.060.986 | 2.412.825 | 3,59% | Hisse senetleri |
| FEDERATED HERMES, INC. | $36.140.959 | 2.352.927 | 3,50% | Hisse senetleri |
| Point72 Asset Management, L.P. | $30.625.336 | 1.993.837 | 2,97% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $28.528.911 | 1.857.351 | 2,76% | Hisse senetleri |
| TCG Crossover Management, LLC | $27.488.517 | 1.789.617 | 2,66% | Hisse senetleri |
| Alyeska Investment Group, L.P. | $25.300.070 | 1.647.140 | 2,45% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $23.153.049 | 1.507.360 | 2,24% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $20.439.706 | 1.330.710 | 1,98% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $18.543.360 | 1.207.250 | 1,80% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $18.499.798 | 1.204.150 | 1,79% | Hisse senetleri |
| CITADEL ADVISORS LLC | $18.443.321 | 1.200.737 | 1,79% | Hisse senetleri |
| ALGERT GLOBAL LLC | $17.063.255 | 1.110.889 | 1,65% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $16.842.378 | 1.096.509 | 1,63% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $14.633.088 | 952.675 | 1,42% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $13.984.665 | 910.460 | 1,35% | Hisse senetleri |
| MORGAN STANLEY | $12.855.801 | 836.966 | 1,24% | Hisse senetleri |
| Nantahala Capital Management, LLC | $12.440.279 | 809.914 | 1,20% | Hisse senetleri |
| Qube Research & Technologies Ltd | $10.783.596 | 702.057 | 1,04% | Hisse senetleri |
| Squarepoint Ops LLC | $8.176.451 | 532.321 | 0,79% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $8.059.392 | 524.700 | 0,78% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $7.749.796 | 504.544 | 0,75% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $6.464.732 | 420.881 | 0,63% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $6.293.960 | 257.527 | 0,61% | Hisse senetleri |
| NORTHERN TRUST CORP | $6.118.902 | 398.366 | 0,59% | Hisse senetleri |
| JANE STREET GROUP, LLC | $6.020.981 | 391.991 | 0,58% | Hisse senetleri |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | $5.782.979 | 376.496 | 0,56% | Hisse senetleri |
| Woodline Partners LP | $5.683.692 | 370.032 | 0,55% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5.670.774 | 369.191 | 0,55% | Hisse senetleri |
| Rock Springs Capital Management LP | $5.637.258 | 367.009 | 0,55% | Hisse senetleri |
| Jump Financial, LLC | $5.555.174 | 361.665 | 0,54% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $5.525.376 | 359.725 | 0,53% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $4.842.563 | 315.271 | 0,47% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $4.133.576 | 269.113 | 0,40% | Hisse senetleri |
| Man Group plc | $3.821.583 | 248.801 | 0,37% | Hisse senetleri |
| Balyasny Asset Management L.P. | $3.250.714 | 211.635 | 0,31% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $3.219.348 | 209.593 | 0,31% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $3.018.040 | 196.487 | 0,29% | Hisse senetleri |
| JPMORGAN CHASE & CO | $2.736.049 | 178.535 | 0,26% | Hisse senetleri |
| Allspring Global Investments Holdings, LLC | $2.434.909 | 166.092 | 0,24% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.403.840 | 156.500 | 0,23% | Satım opsiyonu |
| BML Capital Management, LLC | $2.380.201 | 154.961 | 0,23% | Hisse senetleri |
| UBS Group AG | $2.314.767 | 150.701 | 0,22% | Hisse senetleri |
| Springhill Fund Asset Management (HK) Co Ltd | $2.119.500 | 78.500 | 0,21% | Hisse senetleri |
| Bank of New York Mellon Corp | $2.074.706 | 135.072 | 0,20% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 başvurular | 10 Mart 2025 | 19,90% | Değişiklik | · | SEC |
| Avalon Ventures XI, L.P., Avalon BioVentures SPV I, L.P., Avalon BioVentures I, LP, Avalon Ventures XI GP LLC, ABV SPV I GP LLC, Avalon BioVentures GP, LLC, Kevin Kinsella, Richard Levandov, Braden Bohrmann, Jay Lichter, Ph.D., Tighe Reardon, Sergio G. Duron, Ph.D., Sanford Madigan, Ph.D. ×6 başvurular | 08 Kasım 2024 | · | İlk başvuru | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VIII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×3 başvurular | 09 Ağustos 2024 | · | İlk başvuru | · | SEC |
| Avalon Ventures XI, L.P. (“Avalon Ventures”), Avalon BioVentures SPV I, L.P. (“ABV SPV”), Avalon Bioventures I, LP (“ABV I”), Avalon Ventures XI GP LLC (“Avalon XI GP”), ABV SPV I GP LLC (“ABV SPV GP”), Avalon BioVentures GP, LLC (“ABV GP”), Kevin Kinsella (“Kinsella”), Richard Levandov (“Levandov”), Braden Bohrmann (“Bohrmann”), Jay Lichter, Ph.D. (“Lichter”), Tighe Reardon (“Reardon”), Sergio Duron (“Duron”), Sanford Madigan, Ph.D. (“Madigan”) ×2 başvurular | 16 Kasım 2023 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 24 içeriden öğrenenler · 12 yöneticiler · 11 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| David Alan Campbell | President and CEO | 31 Temmuz 2026 G | 264.742 | 0 | 1 | $-110.829 |
| Tighe Reardon | Acting Chief Financial Officer | 03 Haziran 2024 S | 3.340.018 | 0 | 0 | $0 |
| Janeen Noel Doyle | Chief Corp. & Bus. Dev. Ofcr | 02 Haziran 2026 S | 75.941 | 0 | 1 | $-56.948 |
| Maria Dobek | Vice President, Accounting | 11 Mayıs 2026 S | 32.270 | 0 | 2 | $-48.951 |
| William Go | Chief Medical Officer | 02 Şubat 2026 A | 44.000 | 0 | 0 | $0 |
| Zachariah Mciver | Chief Medical Officer | 02 Ocak 2026 A | 52.286 | 0 | 1 | $-37.263 |
| Thomas Diraimondo | Chief Scientific Officer | 02 Ocak 2026 A | 155.825 | 0 | 1 | $-34.394 |
| Charles M. Winter | Chief Technical Officer | 02 Ocak 2026 A | 106.321 | 0 | 1 | $-32.966 |
| Andrew Hollman Meyer | Chief Business Officer | 02 Ocak 2026 S | 83.095 | 0 | 5 | $-736.652 |
| Byron Robinson | Chief Strategy Officer | 02 Ocak 2025 A | 28.000 | 0 | 0 | $0 |
| Wayne Godfrey | Chief Medical Officer | 03 Ocak 2023 A | · | 0 | 0 | $0 |
| Shahram Salek-Ardakani | Chief Scientific Officer | 03 Ocak 2022 A | · | 0 | 0 | $0 |
| Jake Simson | Yönetim kurulu üyesi | 11 Haziran 2026 A | 11.750 | 0 | 0 | $0 |
| Natasha Hernday | Yönetim kurulu üyesi | 11 Haziran 2026 A | 15.481 | 0 | 0 | $0 |
| Winston Kung | Yönetim kurulu üyesi | 11 Haziran 2026 A | 11.750 | 0 | 0 | $0 |
| Ronald W Barrett | Yönetim kurulu üyesi | 11 Haziran 2026 A | 11.750 | 0 | 0 | $0 |
| Vickie L Capps | Yönetim kurulu üyesi | 11 Haziran 2026 A | 79.598 | 0 | 0 | $0 |
| Eric Dobmeier | Yönetim kurulu üyesi | 11 Haziran 2026 A | 15.481 | 0 | 0 | $0 |
| Alana B. Mcnulty | Yönetim kurulu üyesi | 11 Haziran 2025 A | 6.250 | 0 | 0 | $0 |
| Sheila Gujrathi | Yönetim kurulu üyesi | 11 Haziran 2025 A | 118.889 | 0 | 0 | $0 |
| Stefan Heller | Yönetim kurulu üyesi | 14 Haziran 2022 A | · | 0 | 0 | $0 |
| Peter A. Thompson | Yönetim kurulu üyesi | 14 Haziran 2022 A | 231.098 | 0 | 0 | $0 |
| Jay Lichter | 10% sahip | 13 Eylül 2024 M | 7.000 | 0 | 0 | $0 |
| Bregua Corp | 10% sahip | 15 Haziran 2021 C | 3.749.250 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 29 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IDNA · iShares Trust | 0,98% | 142.050 SH | 11 Eylül 2026 | Günlük |
| BBC · ETFis Series Trust I | 0,75% | 22.923 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,20% | 65.529 NS | 31 Temmuz 2026 | N-PORT |
| ESSC · Strategy Shares | 0,12% | 2.826 NS | 31 Temmuz 2026 | N-PORT |
| IBB · iShares Trust | 0,07% | 435.895 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 4.350 SH | 01 Ekim 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,06% | 895 NS | 31 Temmuz 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 37.644 SH | 19 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 48.130 SH | 01 Ekim 2026 | Günlük |
| FBCG · FIDELITY COVINGTON TRUST | 0,03% | 123.298 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.107.172 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,02% | 20.662 NS | 31 Temmuz 2026 | N-PORT |
| TECB · iShares Trust | 0,02% | 5.624 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 248.060 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 123.038 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 552.164 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 117.899 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 18.188 NS | 31 Temmuz 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.569 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,00% | 5.688 NS | 31 Temmuz 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.318 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 68.785 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 13.661 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.263.837 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.110 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 402.945 SH | 11 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 2.013 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 9.972 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 53.769 SH | 11 Eylül 2026 | Günlük |
JANX Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 26 analist
AL
Medyan hedef
$29.00
+71,3%
10 38,5%
Güçlü Al
12 46,2%
Al
3 11,5%
Tut
1 3,8%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
17 analist · 2026-09-28Ortalama hedef $36.24 +114,0%
Şimdi
Mevcut fiyat $16.93
Düşük$14.00
Ortalama$36.24
Yüksek$75.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
| TRAX | · | · | · | · | · | · |
| VOR | $506M | -0.2 | · | · | 83.4% | · |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | · |
| AKTS | · | · | · | · | · | · |
| ODTX | · | · | · | · | · | · |
| SVRA | $1.23B | -11.4 | · | · | -73.4% | · |
| KURA | $913M | -3.3 | 25.2% | -413.0% | -116.2% | · |
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026